BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7581939)

  • 1. T cell-rich B cell lymphoma bearing Epstein-Barr virus in tumor cells: a case of IBL-T-like lesion following Lennert's lesion.
    Wakatsuki S; Yumoto N; Takagi T; Kurosu K; Sakai C; Tamayama C; Komatsu T; Matsuzaki O; Mikata A
    Pathol Int; 1995 Jun; 45(6):457-62. PubMed ID: 7581939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
    Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
    Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent presence of latent Epstein-Barr virus infection in lymphoepithelioid cell lymphoma (Lennert's lymphoma).
    Anagnostopoulos I; Hummel M; Tiemann M; Korbjuhn P; Parwaresch MR; Stein H
    Histopathology; 1994 Oct; 25(4):331-7. PubMed ID: 7835838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma.
    Tao Q; Srivastava G; Loke SL; Liang RH; Liu YT; Ho FC
    Int J Cancer; 1994 Jul; 58(1):33-9. PubMed ID: 8014013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
    Brown HA; Macon WR; Kurtin PJ; Gibson LE
    J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma.
    Ohshima K; Takeo H; Kikuchi M; Kozuru M; Uike N; Masuda Y; Yoneda S; Takeshita M; Shibata T; Akamatsu M
    Histopathology; 1994 Dec; 25(6):569-79. PubMed ID: 7698734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma?
    Yamashita Y; Nakamura S; Kagami Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Am J Surg Pathol; 2000 Dec; 24(12):1627-33. PubMed ID: 11117783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus.
    Abruzzo LV; Schmidt K; Weiss LM; Jaffe ES; Medeiros LJ; Sander CA; Raffeld M
    Blood; 1993 Jul; 82(1):241-6. PubMed ID: 8391875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
    Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
    Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
    Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
    Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
    Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
    Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
    Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
    Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma.
    Hawley RC; Cankovic M; Zarbo RJ
    Arch Pathol Lab Med; 2006 Nov; 130(11):1707-11. PubMed ID: 17076535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
    Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
    Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
    Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
    Weiss LM; Jaffe ES; Liu XF; Chen YY; Shibata D; Medeiros LJ
    Blood; 1992 Apr; 79(7):1789-95. PubMed ID: 1373088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients.
    Sabourin JC; Kanavaros P; Briere J; Lescs MC; Petrella T; Zafrani ES; Gaulard P
    Am J Surg Pathol; 1993 Oct; 17(10):995-1002. PubMed ID: 8396858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
    Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
    Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.